| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.01. | Arcutis Biotherapeutics, Inc.: ZORYVE (Roflumilast) Topical Foam, 0.3% Clears Seborrheic Dermatitis in Individuals Who Previously Reported an Inadequate Response to Topical Steroids | 288 | GlobeNewswire (Europe) | New subgroup analysis from STRATUM study shows that individuals with an inadequate response, contraindication, or intolerance to steroids were 3.5 times more likely to achieve IGA Success with ZORYVE... ► Artikel lesen | |
| 14.01. | Arcutis Biotherapeutics, Inc.: Majority of Individuals with Atopic Dermatitis Improved with Arcutis' Roflumilast Cream 0.15% According to New Data from Phase 3 Program | 309 | GlobeNewswire (Europe) | Individual patient response data highlight 91.5% of individuals treated with roflumilast cream had a measurable improvement in Eczema Area and Severity Index (EASI) in just 4 weeks85% achieved measurable... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 592 |
| BAYER | 381 |
| BYD | 324 |
| NEL | 307 |
| NVIDIA | 283 |
| TUI | 269 |
| TESLA | 268 |
| PLUG POWER | 262 |
| DEUTSCHE BANK | 261 |
| SUPER MICRO COMPUTER | 243 |
| APPLE | 236 |
| RHEINMETALL | 226 |
| RWE | 214 |
| DEUTSCHE LUFTHANSA | 197 |
| MERCEDES-BENZ | 195 |
| AMAZON | 190 |
| BERKSHIRE HATHAWAY | 185 |
| RENK GROUP | 156 |
| VOLKSWAGEN | 153 |
| COMMERZBANK | 150 |
| ALLIANZ | 149 |
| AIXTRON SE | 147 |
| BIONTECH | 146 |
| PAYPAL | 143 |
| BASF | 139 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
